Financials
- Market Capitalization 1.19 B
- Employee 231
- Founded 2005
- CEO Linda Marban
- Website www.capricor.com
- Headquarter Delaware, United States
- FIGI BBG000DZMK99
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2320 | CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.71 USD | -6.13% | -3.92% | +22.48% | +236.61% | 1.24 B USD | ||
| 2348 | EYPT EyePoint, Inc. - Common Stock | 14.28 USD | -2.99% | -2.53% | +8.68% | +19.00% | 1.20 B USD | ||
| 2359 | SVRA Savara, Inc. - Common Stock | 5.74 USD | -4.81% | -7.42% | +6.89% | +125.98% | 1.18 B USD | ||
| 2379 | WVE Wave Life Sciences Ltd. - Ordinary Shares | 5.95 USD | -4.80% | -7.18% | +1.19% | -16.90% | 1.14 B USD |
Frequently asked questions about Capricor Therapeutics, Inc. - Common Stock
What is the Capricor Therapeutics, Inc. - Common Stock stock price today?
The current price of Capricor Therapeutics, Inc. - Common Stock (CAPR) is 20.61. Over the past 24 hours, the stock has changed by -4.18%. Follow the CAPR chart for real-time price dynamics.
What is the stock ticker of Capricor Therapeutics, Inc. - Common Stock?
Capricor Therapeutics, Inc. - Common Stock trades under the ticker CAPR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Capricor Therapeutics, Inc. - Common Stock stock going up?
CAPR has changed by -8.56% over the last week, -20.85% over the last month, and +179.65% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Capricor Therapeutics, Inc. - Common Stock net income for the last quarter?
Capricor Therapeutics, Inc. - Common Stock reported net income of -33.94 M for the last quarter. The previous quarter showed -30.17 M, which means net income changed by -12.50%.
How many employees does Capricor Therapeutics, Inc. - Common Stock have?
As of the latest available data, Capricor Therapeutics, Inc. - Common Stock has 231 employees. Workforce size can provide additional context about the company's scale and operations.
What is Capricor Therapeutics, Inc. - Common Stock EBITDA?
Capricor Therapeutics, Inc. - Common Stock EBITDA is -36.23 M, and its EBITDA margin is -444.81 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Capricor Therapeutics, Inc. - Common Stock stock?
You can buy Capricor Therapeutics, Inc. - Common Stock (CAPR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Capricor Therapeutics, Inc. - Common Stock stock?
Investing in Capricor Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CAPR chart and related analysis on metatrader.com as part of your research.